Concepedia

Author

Lynnette Marcar

University of Dundee

Also Known As

L. Marcar, Lynnette Marcar

27

Publications

898

Citations

12

H-Index

14

Concepts

All Affiliations

University of DundeeNinewells HospitalUniversity of LimerickMassachusetts General HospitalCenter for Cancer Research
LM

About

Lynnette Marcar is an author at University of Dundee specializing in medicine, cancer research, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

96

2

Cell Biology

2

2

96

3

Immunology

1

1

41

4

Molecular Biology

1

1

41

5

Immunotherapy

1

1

41

Lynnette Marcar

×

11

Publications

793

Citations

11

H-Index

YearCitations

Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin

Lynnette Marcar, Nicola J. MacLaine, Ted R. Hupp,

Cancer Research

2010

169

p53-dependent repression of polo-like kinase-1 (PLK1)

Lynsey McKenzie, Sharon King, Lynnette Marcar,

Cell Cycle

2010

111

Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway

Meng Wang, Jing Han, Lynnette Marcar,

Cancer Research

2017

103

Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma

Carol Hogan, Caroline Hutchison, Lynnette Marcar,

Journal of Biological Chemistry

2008

81

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas

Lucia Mundo, Leonardo Del Porro, Massimo Granai,

Modern Pathology

2020

69

FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53

Anna Maria Ochocka, Petros Kampanis, Samantha M. Nicol,

FEBS Letters

2009

66

Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity

Lynnette Marcar, Kankana Bardhan, Liliana Gheorghiu,

Cell Reports

2019

64

PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53

Qi Liu, Liliana Gheorghiu, Michael Drumm,

Oncogene

2018

55

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4

Lynnette Marcar, Bianca Ihrig, John M Hourihan,

PLoS ONE

2015

41

Identification of Nanoparticle Properties for Optimal Drug Delivery across a Physiological Cell Barrier

Aisling M. Ross, Rachel M. Cahalane, Darragh R. Walsh,

Pharmaceutics

2023

21

Page 1